The impact of disease recurrence on graft survival following liver transplantation: a single centre experience

• Published in: Transplant international Vol. 21; no. 5; pp. 459 - 465
• Main Authors: Rowe, Ian A, Webb, Kerry, Gunson, Bridget K, Mehta, Naimish, Haque, Sayeed, Neuberger, James
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.05.2008
• Subjects: Adult; autoimmune liver disease; Graft Survival; Hepatitis C - surgery; Hepatitis C virus; Hepatitis, Autoimmune - surgery; Humans; Liver Cirrhosis, Biliary - surgery; liver transplant; Liver Transplantation; Middle Aged; Recurrence; recurrent disease; Retrospective Studies; Time Factors
• ISSN: 0934-0874; 1432-2277
• DOI: 10.1111/j.1432-2277.2007.00628.x

Summary Many diseases that cause liver failure may recur after transplantation. A retrospective analysis of the rate and cause of graft loss of 1840 consecutive adults receiving a primary liver transplant between 1982 and 2004 was performed to evaluate the rate of graft loss from disease recurrence. The risk of graft loss from recurrent disease was greatest, when compared to primary biliary cirrhosis (PBC), in those transplanted for hepatitis C virus (HCV) [hazard ratio (HR) 11.6; 95% confidence interval (CI) 5.1–26.6], primary sclerosing cholangitis (PSC) (HR 6.0; 95% CI 2.5–14.2) and autoimmune hepatitis (AIH) (HR 4.1; 95% CI 1.3–12.6). The overall risk of graft loss was also significantly greater in HCV (HR 2.1 vs. PBC; 95% CI 1.5–3.0), PSC (HR 1.6 vs. PBC; 95% CI 1.2–2.3) and AIH (HR 1.6; 95% CI 1.0–2.4) than in PBC. There was no statistically significant difference in the risk of graft loss because of recurrent disease, when compared with PBC, for patients transplanted for alcohol related liver disease, nonalcoholic steatohepatitis and fulminant hepatic failure. Disease recurrence is a significant cause of graft loss particularly in HCV, PSC and AIH. Recurrent disease, in part, explains the increased overall risk of graft loss in these groups.